HK1059618A1 - Process for the isolation and purification of epothilones. - Google Patents

Process for the isolation and purification of epothilones.

Info

Publication number
HK1059618A1
HK1059618A1 HK04100923A HK04100923A HK1059618A1 HK 1059618 A1 HK1059618 A1 HK 1059618A1 HK 04100923 A HK04100923 A HK 04100923A HK 04100923 A HK04100923 A HK 04100923A HK 1059618 A1 HK1059618 A1 HK 1059618A1
Authority
HK
Hong Kong
Prior art keywords
epothilones
isolation
purification
Prior art date
Application number
HK04100923A
Other languages
English (en)
Inventor
Ernst Kusters
Heinz Unternahrer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1059618A1 publication Critical patent/HK1059618A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silicon Polymers (AREA)
  • Saccharide Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
HK04100923A 2000-12-07 2004-02-11 Process for the isolation and purification of epothilones. HK1059618A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029895.0A GB0029895D0 (en) 2000-12-07 2000-12-07 Organic compounds
PCT/EP2001/014771 WO2002046196A1 (en) 2000-12-07 2001-12-05 Process for the isolation and purification of epothilones

Publications (1)

Publication Number Publication Date
HK1059618A1 true HK1059618A1 (en) 2004-07-09

Family

ID=9904660

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04100923A HK1059618A1 (en) 2000-12-07 2004-02-11 Process for the isolation and purification of epothilones.

Country Status (32)

Country Link
US (2) US6946561B2 (ja)
EP (1) EP1345944B1 (ja)
JP (1) JP4287650B2 (ja)
KR (1) KR100894990B1 (ja)
CN (1) CN1263761C (ja)
AR (1) AR031902A1 (ja)
AT (1) ATE292132T1 (ja)
AU (2) AU2493602A (ja)
BR (1) BR0115991A (ja)
CA (1) CA2433414C (ja)
CZ (1) CZ301664B6 (ja)
DE (1) DE60109814T2 (ja)
DK (1) DK1345944T3 (ja)
EC (1) ECSP034641A (ja)
ES (1) ES2239687T3 (ja)
GB (1) GB0029895D0 (ja)
HK (1) HK1059618A1 (ja)
HU (1) HU224910B1 (ja)
IL (2) IL156088A0 (ja)
MX (1) MXPA03005097A (ja)
MY (1) MY128409A (ja)
NO (1) NO329164B1 (ja)
NZ (1) NZ526197A (ja)
PE (1) PE20020568A1 (ja)
PL (1) PL209406B1 (ja)
PT (1) PT1345944E (ja)
RU (1) RU2285007C2 (ja)
SI (1) SI1345944T1 (ja)
SK (1) SK287356B6 (ja)
TW (1) TWI286137B (ja)
WO (1) WO2002046196A1 (ja)
ZA (1) ZA200304296B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867305B2 (en) 1996-12-03 2005-03-15 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
EP1386922B1 (en) * 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereof, analogues and uses thereof
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
GB0029895D0 (en) * 2000-12-07 2001-01-24 Novartis Ag Organic compounds
MXPA05002113A (es) * 2002-08-23 2005-06-03 Sloan Kettering Inst Cancer Sintesis de epotilonas, intermediarios para ellas, analogos y usos de los mismos.
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
AU2003275068B2 (en) * 2002-09-23 2009-09-17 Bristol-Myers Squibb Company Methods for the preparation, isolation and purification of epothilone B, and X-Ray crystal structures of epothilone B
FR2846520B1 (fr) 2002-11-06 2006-09-29 Roquette Freres Utilisation de maltodextrines branchees comme liants de granulation
KR100681811B1 (ko) * 2005-03-15 2007-02-12 성균관대학교산학협력단 생물학적 대사부산물의 효율적인 제거를 통한 유용 이차대사산물의 제조방법
PE20081317A1 (es) 2006-08-16 2008-10-28 Novartis Ag Formas de cristal de la epotilona b
WO2009100571A1 (zh) 2008-02-01 2009-08-20 Zhejiang Hisun Pharmaceutical Co., Ltd. 一种分离和提纯埃博霉素的方法
CN105797168A (zh) 2010-05-18 2016-07-27 天蓝制药公司 用于治疗自身免疫性疾病或其它疾病的组合物和方法
KR101372563B1 (ko) * 2011-12-26 2014-03-14 주식회사 삼양바이오팜 에포틸론 함유물질로부터 에포틸론 a와 b의 추출 및 정제 방법
CN110964029B (zh) * 2019-12-19 2020-11-03 鲁南制药集团股份有限公司 一种埃博霉素b发酵液的预处理方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) * 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
CA2269118C (en) * 1996-11-18 2012-05-29 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Epothilone c, d, e and f, production process, and their use as cytostatic as well as phytosanitary agents
DE19833750A1 (de) * 1997-07-16 1999-02-25 Schering Ag Thiazolderivate, Verfahren zur Herstellung und Verwendung
US6365749B1 (en) * 1997-12-04 2002-04-02 Bristol-Myers Squibb Company Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
DE19826988A1 (de) * 1998-06-18 1999-12-23 Biotechnolog Forschung Gmbh Epothilon-Nebenkomponenten
ATE309369T1 (de) * 2000-04-28 2005-11-15 Kosan Biosciences Inc Heterologe herstellung von polyketiden
GB0029895D0 (en) * 2000-12-07 2001-01-24 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
NO329164B1 (no) 2010-09-06
NZ526197A (en) 2005-01-28
US20040054188A1 (en) 2004-03-18
DE60109814D1 (de) 2005-05-04
US7569698B2 (en) 2009-08-04
NO20032591L (no) 2003-06-06
TWI286137B (en) 2007-09-01
US6946561B2 (en) 2005-09-20
PE20020568A1 (es) 2002-07-22
HU224910B1 (en) 2006-04-28
GB0029895D0 (en) 2001-01-24
AU2493602A (en) 2002-06-18
IL156088A0 (en) 2003-12-23
SK287356B6 (sk) 2010-08-09
MY128409A (en) 2007-01-31
IL156088A (en) 2008-08-07
CN1479741A (zh) 2004-03-03
NO20032591D0 (no) 2003-06-06
EP1345944A1 (en) 2003-09-24
RU2285007C2 (ru) 2006-10-10
SI1345944T1 (sl) 2005-12-31
PT1345944E (pt) 2005-08-31
PL361884A1 (en) 2004-10-04
DE60109814T2 (de) 2006-02-16
ATE292132T1 (de) 2005-04-15
WO2002046196A1 (en) 2002-06-13
AR031902A1 (es) 2003-10-08
MXPA03005097A (es) 2003-09-05
PL209406B1 (pl) 2011-08-31
JP2004521879A (ja) 2004-07-22
ZA200304296B (en) 2004-04-23
CZ301664B6 (cs) 2010-05-19
CN1263761C (zh) 2006-07-12
KR20030053535A (ko) 2003-06-28
ECSP034641A (es) 2003-07-25
HUP0302579A2 (hu) 2003-11-28
CA2433414A1 (en) 2002-06-13
CZ20031565A3 (cs) 2003-10-15
HUP0302579A3 (en) 2004-10-28
JP4287650B2 (ja) 2009-07-01
AU2002224936B2 (en) 2005-09-22
BR0115991A (pt) 2004-01-13
CA2433414C (en) 2011-01-25
KR100894990B1 (ko) 2009-04-24
ES2239687T3 (es) 2005-10-01
US20050288514A1 (en) 2005-12-29
SK6892003A3 (en) 2004-01-08
DK1345944T3 (da) 2005-05-30
EP1345944B1 (en) 2005-03-30

Similar Documents

Publication Publication Date Title
IL222455A0 (en) Methods for the preparation, isolation and purification of epothilone b
AU2001265183A1 (en) Process for the purification of olefins
AU4882301A (en) Method for the purification of propylene oxide
AU7902501A (en) Fermentation process for epothilones
HU0103291D0 (en) Process for the preparation of citalopram
HK1059618A1 (en) Process for the isolation and purification of epothilones.
PL359560A1 (en) Process for the isolation of lovastatin
IL150019A0 (en) Process for the alleviation of anxiety
HUP0301824A3 (en) Process for the cyanation of aldehydes
ZA200109476B (en) Process for the adaptation of flavor mixtures.
MXPA03003347A (es) Procedimiento para purificacion de pravastatina.
GB0020717D0 (en) Novel compounds and process
MXPA03002464A (es) Proceso para preparar benzotriazoles.
EP1191015A4 (en) AMINO STYRENE R THEN DERIVATIVES, INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND METHOD FOR THE PRODUCTION OF BOTH
IL156359A0 (en) Process for the preparation of 4-haloalkylnicotinonitriles
EP1320367A4 (en) PROCESS FOR THE PRODUCTION OF DINAPSOLIN
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
ZA200309288B (en) Process for the isolation of crystalline imipenem.
MXPA03001550A (es) Proceso catalitico para la preparacion de derivados de tiazol.
EG22846A (en) Process for the preparation of urea
ZA200101058B (en) Process for the treatment of gases.
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
AU2001286489A1 (en) Process for the purification of iosoctane and/or diisobutylene
AP2003002913A0 (en) Process for the isolation of crystalline imipenem.
AU7400401A (en) Method for the production of 2- coumarone and substituted 2-coumarones

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131205